CAS: 728033-96-3 - OSI-930
Formula:C22H16F3N3O2S
- Synonyms:
- 3-[(4-Quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide
- OSI 930
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | OSI-930 REF: IN-DA00FC0PCAS: 728033-96-3 | % | 49.00 €~516.00 € | Wed 12 Feb 25 |
 | OSI-930 REF: 4Z-K-031062CAS: 728033-96-3 | - - - | To inquire | Wed 19 Feb 25 |
 | OSI-930 REF: TM-T2624CAS: 728033-96-3 | 99.76% | 45.00 €~605.00 € | Wed 19 Feb 25 |
 | 3-[(4-Quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide REF: 3D-FQ43345CAS: 728033-96-3 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00FC0P
| 1mg | 49.00 € | ||
| 5mg | 81.00 € | ||
| 10mg | 110.00 € | ||
| 25mg | 179.00 € | ||
| 50mg | 203.00 € |
Estimated delivery in United States, on Wednesday 12 Feb 2025
Ref: 4Z-K-031062
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
OSI-930
CAS:728033-96-3
OSI-930 is an oral c-Kit/VEGFR-2 inhibitor targeting tumor growth and angiogenesis.
Formula:
C22H16F3N3O2S
Purity:
99.76%
Color and Shape:
Solid
Molecular weight:
443.44
Ref: TM-T2624
| 1mg | 51.00 € | ||
| 5mg | 100.00 € | ||
| 10mg | 143.00 € | ||
| 25mg | 259.00 € | ||
| 50mg | 419.00 € | ||
| 100mg | 605.00 € | ||
| 1mL*10mM (DMSO) | 100.00 € |
Estimated delivery in United States, on Wednesday 19 Feb 2025
![3-[(4-Quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide](https://static.cymitquimica.com/products/3D/thumb/FQ43345.jpg)
3-[(4-Quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide
CAS:728033-96-3
3-[(4-Quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide is an experimental drug that has been shown to be effective in treating depression …
Purity:
Min. 95%
Ref: 3D-FQ43345
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information |
